CAS 251356-45-3

SU 16f

CAS: 251356-45-3

Fórmula: C₂₄H₂₂N₂O₃

Pureza: 98%

Peso molecular: 386.4431

Ref: IN-DA00C4IJ

SU16f

CAS: 251356-45-3

SU16f

Pureza: ≥95%

Peso molecular: 386.44g/mol

Ref: 54-BUP09360

PDGFR Tyrosine Kinase Inhibitor VII

CAS: 251356-45-3

PDGFR Tyrosine Kinase Inhibitor VII is a protein-based drug that binds to the PDGFR tyrosine kinase receptor and inhibits its activity. This binding prevents the activation of the PDGFR, which is necessary for cell signaling. PDGFR Tyrosine Kinase Inhibitor VII has been shown to be effective against cancer cells in vitro and in vivo. It is also used as a complementary treatment for patients with chronic myelogenous leukemia. The mechanism of action of PDGFR Tyrosine Kinase Inhibitor VII is to inhibit the growth and spread of cancer cells by preventing them from proliferating.

Fórmula: C₂₄H₂₂N₂O₃

Pureza: Min. 95%

Peso molecular: 386.44 g/mol

Ref: 3D-BKA35645

SU16f

CAS: 251356-45-3

SU16f, a 3-substituted indolin-2-one, is a selective PDGFRβ inhibitor; IC50: 10 nM (PDGFRβ), 140 nM (PDGFR1), 2.29 μM (PDGFR2), halts GC cell growth.

Fórmula: C₂₄H₂₂N₂O₃

Pureza: 97.69%

Cor e Forma: Solid

Peso molecular: 386.44

Ref: TM-T16947